Liver-directed AAV gene therapy in mice corrects glycogen storage disease type IX γ2. - Gibson RA; Jeck WR; Koch RL; Jumani N; Choi SJ; Bali D; Young SP; Asokan A; Lim JA; Kishnani PS (Science advances, 2025)